Product Images Ipratropium Bromide And Albuterol Sulfate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Ipratropium Bromide And Albuterol Sulfate NDC 68788-8103 by Preferred Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Ipratropium Bromide 05mg and Albuterol Sulfate 3mg Inh Sol. - 66F32A06 C880 4B5B 837B 951E1E01E040 00

Ipratropium Bromide 05mg and Albuterol Sulfate 3mg Inh Sol. - 66F32A06 C880 4B5B 837B 951E1E01E040 00

This is a description of a medication called Ipratropium Bromide and Albuterol Sulfate inhalation solution, which comes in a 3mL unit-dose vial containing 0.5mg of ipratropium bromide and 3mg of albuterol sulfate. The medication is a generic version of Duoneb, used for oral inhalation. The packaging includes an expiration date and lot/batch numbers, and it is manufactured by Nephron SC Inc. The directions are not available in this text, and it includes a warning against transferring the drug to anyone other than the prescribed patient. It should be stored at temperatures between 2°C and 23°C, out of reach of children. The text includes several repetitions of the medication's name, lot/batch numbers, and production number, which could be related to inventory or distribution purposes.*

b5387e98-figure-01 - b5387e98 figure 01

b5387e98-figure-01 - b5387e98 figure 01

b5387e98-figure-02 - b5387e98 figure 02

b5387e98-figure-02 - b5387e98 figure 02

b5387e98-figure-03 - b5387e98 figure 03

b5387e98-figure-03 - b5387e98 figure 03

The text appears to be a mixture of numerical values, symbols, and a drug's name. The description of the drug is Albuterol and Ipratropium mixed together to create Mimutoral Sulfote Inhalation Solution. The rest of the text seems to be unreadable due to errors in .*

b5387e98-figure-04 - b5387e98 figure 04

b5387e98-figure-04 - b5387e98 figure 04

This is a report on adverse events caused by three different drugs used for respiratory conditions, namely Albuterol, Ipratropium, and Ipratropium Bromide. The report provides the number and percentage of patients who experienced adverse effects out of the total number of patients for each drug. Additionally, the report lists adverse events that occurred in more than 1% of patients in any one of the groups and where the combination treatment showed the highest percentage. The adverse events are grouped under different body systems, detailing the number and percentage of patients for each adverse event.*

b5387e98-figure-05 - b5387e98 figure 05

b5387e98-figure-05 - b5387e98 figure 05

b5387e98-figure-06 - b5387e98 figure 06

b5387e98-figure-06 - b5387e98 figure 06

b5387e98-figure-07 - b5387e98 figure 07

b5387e98-figure-07 - b5387e98 figure 07

b5387e98-figure-08 - b5387e98 figure 08

b5387e98-figure-08 - b5387e98 figure 08

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.